4 Antiphospholipid Syndrome Clinical Trials in Rochester, MN (2026)

Q: How do I join a clinical trial in Rochester?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you.

Recruiting Antiphospholipid Syndrome Studies in Rochester

NCT06375044Recruiting

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

This is an open-label, multicenter phase 1 clinical trial to evaluate the safety and tolerability, efficacy, and pharmacokinetics of SIM0500 in adult participants with Relapsed or Refractory Multiple ...

Rochester, MNPHASE1130 participantsJiangsu Simcere Pharmaceutical Co., Ltd.

View Study Details

NCT06433947Recruiting

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

Phase 1b, open-label study evaluating the safety, tolerability, pharmacokinetics, preliminary antitumor activity, and pharmacodynamics of OPN-6602 monotherapy and in combination with dexamethasone in ...

Rochester, MNPHASE1130 participantsOpna Bio LLC

View Study Details

NCT06549790Recruiting

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

The aim of PERKA-812-003 study is to investigate the safety, pharmacokinetics and preliminary anti-tumor activity of treatment with NMS-03597812 as single agent in Relapsed/Refractory Acute Myeloid Le...

Rochester, MNPHASE1124 participantsNerviano Medical Sciences

View Study Details

NCT05671757Recruiting

Daratumumab in Primary Antiphospholipid Syndrome

The purpose of this study is to see if the study medication, daratumumab, is safe to treat individuals with Anti-Phospholipid Syndrome (APS). Three daratumumab dosing cohorts are planned with up to s...

Rochester, MNPHASE122 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

About Antiphospholipid Syndrome Clinical Trials in Rochester

Antiphospholipid syndrome is an autoimmune disorder that increases the risk of blood clots in arteries and veins, and pregnancy complications. It occurs when the immune system makes antibodies that attack phospholipids. Treatment primarily involves anticoagulant medications.

There are currently 4 antiphospholipid syndrome clinical trials recruiting participants in Rochester, MN. These studies are seeking a combined 406 participants. Research is being sponsored by Jiangsu Simcere Pharmaceutical Co., Ltd., Opna Bio LLC, Nerviano Medical Sciences and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Antiphospholipid Syndrome Clinical Trials in Rochester — FAQ

Are there antiphospholipid syndrome clinical trials in Rochester?

Yes, there are 4 antiphospholipid syndrome clinical trials currently recruiting in Rochester, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What antiphospholipid syndrome treatments are being tested?

The 4 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for antiphospholipid syndrome.

Data updated October 16, 2026 from ClinicalTrials.gov